Get the Stockscreener App
4.48
4.27%
-0.20
Clover Health Investments Corp stock is traded at $4.48, with a volume of 3.64M.
It is down -4.27% in the last 24 hours and down -1.75% over the past month.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
See More
Previous Close:
$4.68
Open:
$4.68
24h Volume:
3.64M
Relative Volume:
0.73
Market Cap:
$2.38B
Revenue:
$2.21B
Net Income/Loss:
$-56.94M
P/E Ratio:
-39.86
EPS:
-0.1124
Net Cash Flow:
$54.54M
1W Performance:
-6.47%
1M Performance:
-1.75%
6M Performance:
+107.41%
1Y Performance:
+65.93%
1-Day Range:
$4.46
$4.707
1-Week Range:
$4.46
$4.90
52-Week Range:
$1.58
$5.59
Clover Health Investments Corp Stock (CLOV) Company Profile
Name
Clover Health Investments Corp
Sector
Industry
Phone
(201) 432-2133
Address
30 MONTGOMERY STREET, JERSEY CITY
Compare CLOV vs UNH, CVS, ELV, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLOV
Clover Health Investments Corp
|
4.48 | 2.38B | 2.21B | -56.94M | 54.54M | -0.1124 |
UNH
Unitedhealth Group Inc
|
401.43 | 360.32B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
92.36 | 118.13B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
428.26 | 92.88B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
302.30 | 79.88B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
413.16 | 49.61B | 137.20B | 1.15B | 1.27B | 9.3439 |
Clover Health Investments Corp Stock (CLOV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-10-26 | Initiated | Deutsche Bank | Buy |
| Dec-17-24 | Initiated | Craig Hallum | Buy |
| Oct-07-24 | Initiated | UBS | Neutral |
| Feb-02-22 | Initiated | Canaccord Genuity | Buy |
| Feb-02-22 | Upgrade | Cowen | Underperform → Market Perform |
| Jan-19-22 | Initiated | SVB Leerink | Mkt Perform |
| Jan-10-22 | Resumed | Citigroup | Neutral |
| Jan-07-22 | Downgrade | Credit Suisse | Neutral → Underperform |
| Sep-10-21 | Initiated | Cowen | Underperform |
| Sep-02-21 | Resumed | Citigroup | Neutral |
| Jul-12-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Jun-10-21 | Downgrade | BofA Securities | Neutral → Underperform |
| May-17-21 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-09-21 | Initiated | Credit Suisse | Neutral |
| Feb-02-21 | Initiated | Citigroup | Buy |
| Feb-01-21 | Initiated | JP Morgan | Neutral |
View All
Clover Health Investments Corp Stock (CLOV) Latest News
Clover Health Investments Corp. (US18914F1030.SG) stock historical prices and data - Yahoo Finance UK
Form 144 Clover Health Investments For: 15 October By Investing.com - Investing.com Nigeria
To cover taxes, Clover Health (CLOV) officer Andrew Toy proposes selling 60,765 shares. - Stock Titan
A proposed $21K share sale would cover stock-vesting taxes for a Clover Health (CLOV) officer. - Stock Titan
Tax withholding prompts a proposed 14,341-share sale by Clover Health (CLOV) officer Karen M. Soares. - Stock Titan
To cover taxes, a Clover Health (CLOV) officer proposes selling 17,858 shares valued at $83.6K. - Stock Titan
3 Penny Stocks With Market Caps Up To $3B - Simply Wall Street
Clover Health Investments, Corp. Tokenized Stock (Coinbase) News - CoinMarketCap
Clover Health Investments, Corp. (NASDAQ:CLOV) Stock Rated "Hold" by Wall Street Analysts - MarketBeat
Clover Health: Star Plan Rating Buoys ItWhy I'm (Cautiously) Long-Term Bullish (CLOV) - Seeking Alpha
Clover Health: Star Plan Rating Buoys ItWhy I'm (Cautiously) Long-Term Bullish (CLOV) - Seeking Alpha
Discover Power Solutions International And 2 More Leading Growth Stocks With Insider Ownership - Simply Wall Street
Form 144 Clover Health Investments For: 11 October By Investing.com - Investing.com South Africa
Form 144 Clover Health Investments For: 11 October By Investing.com - Investing.com Nigeria
Clover Health Investments (CLOV) Is Up 9.4% After Securing 5-Star PPO CMS Rating For 2027 - Yahoo Finance
Clover Health (CLOV) Stock Looks In Line Despite 5 Star Medicare News - Yahoo! Finance Canada
Clover Health (CLOV) Stock Looks In Line Despite 5 Star Medicare News - Yahoo Finance
Why Is Clover Health (CLOV) Stock Soaring Today - Yahoo Finance
Clover Health Stock Pops: What's Happening? - Benzinga
Clover Health Investments (NASDAQ:CLOV) Shares Gap UpStill a Buy? - MarketBeat
Why Is Clover Health (CLOV) Stock Soaring Today - Barchart.com
Is Clover Health Stock Too Dependent On One Group Of Members? - Yahoo Finance
Clover Health Medicare Advantage PPO Plans Earn 5-Star Rating; HMO at 4.5 Stars - TradingView
Global Insurtech Market Size, Share, Trends, and Forecast to 2035 | AI, Cloud, and Automation Drive 41.45% CAGR, Creating a USD 638 Billion Opportunity - GlobeNewswire Inc.
Clover Health (CLOV) Medicare Advantage PPO Plans Earn 5-Star CM - GuruFocus
Clover Health Medicare Advantage PPO Plans Earn 5 Star Rating for 2027 - GlobeNewswire Inc.
Clover Health Medicare Advantage PPO Plans Earn 5 Star Rating for 2027 - Moomoo
Clover Health (CLOV) Shares Rise 8.5% After Medicare Advantage S - GuruFocus
Clover Health sets results date. Deutsche Bank sets USD 6.00 target for Clover Health stock - AD HOC NEWS
Clover Health to present at Jefferies and Deutsche Bank conferences - scanx.trade
Clover Health (CLOV) CEO Jamie Reynoso Sells 2,006 Shares as Sto - GuruFocus
Clover Health Medicare Advantage CEO Jamie Reynoso sells $9,287 in stock - Investing.com Nigeria
Form 4 Clover Health Investments Corp For: 7 October By Investing.com - Investing.com India
Clover Health Q3FY26 Results: Earnings call set for Nov 4, 2026 - scanx.trade
Under a trading plan, Jamie L. Reynoso sells Clover Health (CLOV) shares at $4.63 on average. - Stock Titan
Officer Jamie Reynoso plans to sell 2,006 Clover Health (CLOV) shares. - Stock Titan
Clover Health to Report Third Quarter 2026 Financial Results on November 4, 2026 - The Manila Times
Clover Health to Report Third Quarter 2026 Financial Results on November 4, 2026 - Moomoo
Clover Health CEO, Medicare Advantage, sells $38,675 of CLOV shares By Investing.com - Investing.com Nigeria
Form 4 Clover Health Investments Corp For: 6 October By Investing.com - Investing.com Canada
Clover Health CEO, Medicare Advantage, sells $38,675 of CLOV shares By Investing.com - Investing.com Canada
Form 4 Clover Health Investments Corp For: 6 October By Investing.com - Investing.com UK
An executive sells 8,750 Clover Health (CLOV) shares in a mandatory sale to cover taxes. - Stock Titan
An officer proposes selling 8,706 Clover Health (CLOV) shares to cover stock-award taxes. - Stock Titan
Why is Clover Health (NASDAQ:CLOV) stock in focus as Medicare plans roll out? - Kalkine Media
What Is Clover Health (NASDAQ:CLOV) Offering As Annual Enrollment Nears? - Kalkine Media
Have Insiders Sold Clover Health Investments Shares Recently? - Moomoo
Clover Health Investments (CLOV) Unveils 2027 Medicare Plans, Is The Stock Still Cheap? - Yahoo Finance
Clover Health Investments (NASDAQ:CLOV) CEO Sells 318,806 Shares of Company Stock - MarketBeat
Clover Health Director Robert G. Torricelli Granted 12,481 RSUs in September 2026 - Kalkine Media
Clover Health Investments Corp Stock (CLOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Clover Health Investments Corp Stock (CLOV) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Joseph Clay Thornton | Officer |
Oct 15 '26 |
Proposed Sale |
4.68 |
4,487 |
20,999 |
0 |
| Jamie Reynoso | Officer |
Oct 15 '26 |
Proposed Sale |
4.68 |
17,858 |
83,575 |
0 |
| Karen M. Soares | Officer |
Oct 15 '26 |
Proposed Sale |
4.68 |
14,341 |
67,116 |
0 |
| Conrad Wai | Officer |
Oct 15 '26 |
Proposed Sale |
4.68 |
23,463 |
109,807 |
0 |
| JAMIE REYNOSO | Officer |
Oct 07 '26 |
Proposed Sale |
4.60 |
2,006 |
9,228 |
0 |
| Reynoso Jamie L. | CEO, Medicare Advantage |
Oct 07 '26 |
Sale |
4.63 |
2,006 |
9,288 |
2,792,690 |
| Jamie Reynoso | Officer |
Oct 05 '26 |
Proposed Sale |
4.68 |
8,706 |
40,744 |
0 |
| Reynoso Jamie L. | CEO, Medicare Advantage |
Oct 05 '26 |
Sale |
4.42 |
8,750 |
38,675 |
2,794,696 |
| Toy Andrew | Chief Executive Officer |
Oct 01 '26 |
Sale |
4.19 |
318,806 |
1,335,797 |
9,140,510 |
| Andrew Toy | Officer |
Oct 01 '26 |
Proposed Sale |
4.23 |
309,558 |
1,309,430 |
0 |
2.17%
1.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):